Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
01/10/2001 | EP1066506A1 Method and apparatus for synthesis of arrays of dna probes |
01/10/2001 | EP1066505A1 Apparatus and method for infectious disease detection |
01/10/2001 | EP1066411A1 Methods for cancer prognosis and screening antiproliferative agents |
01/10/2001 | EP1066408A1 A novel method of detecting and monitoring endometrial and uterine cancers |
01/10/2001 | EP1066404A1 Methods for producing libraries of expressible gene sequences |
01/10/2001 | EP1066402A1 Methods of screening agents for activity using teleosts |
01/10/2001 | EP1066394A2 Novel basal endosperm transfer cell layer (betl) specific genes |
01/10/2001 | EP1066390A2 Methods of cancer diagnosis using a chimeric toxin |
01/10/2001 | EP1066380A2 Soluble t cell receptor |
01/10/2001 | EP1066379A1 Protein variant of the net1 locus |
01/10/2001 | EP1066378A2 Lyst protein complexes and lyst interacting proteins |
01/10/2001 | EP1066376A1 Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines |
01/10/2001 | EP1066369A1 Selection subtraction approach to gene identification |
01/10/2001 | EP1066368A1 Selective cell analysis |
01/10/2001 | EP1066328A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production |
01/10/2001 | EP1066321A2 Formulation having a papilloma virus-specific protein, and the production and use thereof |
01/10/2001 | EP1066320A1 Orphan nuclear receptor |
01/10/2001 | EP1066319A1 Production methods and uses of a retrovirus |
01/10/2001 | EP1066315A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
01/10/2001 | EP1066311A1 Compositions and methods for the identification of lung tumor cells |
01/10/2001 | EP1066051A1 Sciellin and uses thereof |
01/10/2001 | EP1066042A2 Steroidal saponins for treating alzheimer's disease |
01/10/2001 | EP1066033A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
01/10/2001 | EP0989912A4 Filter plate |
01/10/2001 | EP0906570B1 Process to eliminate haemoglobin errors when analysing medical samples |
01/10/2001 | EP0898557A4 Water soluble tri-substituted 1,2-dioxetane compounds having increased storage stability, synthetic processes and intermediates |
01/10/2001 | EP0863770A4 Contrast medium and its use |
01/10/2001 | EP0642667B1 Screening method for identifying women at increased risk for preterm delivery |
01/10/2001 | EP0555216B2 Process and apparatus for analysis of hydrocarbons by near-infrared spectroscopy |
01/10/2001 | CN1279764A Method and apparatus for making quantitave measurements of localized accumulations of magnetic particles |
01/10/2001 | CN1279691A Antibodise against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
01/10/2001 | CN1279689A Vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
01/10/2001 | CN1279399A Reagent kit for discriminating diabetes and its preparing process |
01/10/2001 | CN1279292A Phytolipoase table for quickly detecting agricultural chemical of organophosphorus |
01/09/2001 | US6173237 Optimization process of a bitumen/polymers mixture |
01/09/2001 | US6172744 Method and apparatus for performing spectroscopic analysis with applicability to samples with turbidity and absorption |
01/09/2001 | US6172367 Method and device for measuring electromagnetic waves emanating from a melt |
01/09/2001 | US6172278 Ikaros transgenic cells and mice |
01/09/2001 | US6172261 Biosynthesis using chain extension |
01/09/2001 | US6172218 Oligonucleotide tags for sorting and identification |
01/09/2001 | US6172214 Oligonucleotide tags for sorting and identification |
01/09/2001 | US6172211 Nucleotide sequences which codes a protein that modulates tumor propagation; for the treatment of cancer; antitumor agents; anticarcinogenic agents; antiproliferative agents |
01/09/2001 | US6172201 Cellular receptor for HIV-1 Vpr essential for G2/M phase |
01/09/2001 | US6172200 Monoclonal antibody that preferentially binds protein; for use as diagnostic tool in analyzing embryonic development and cellular regulation; for the detection of modulators of gene expression |
01/09/2001 | US6172194 ARF-p19, a novel regulator of the mammalian cell cycle |
01/09/2001 | US6172193 Escape mutant of the surface antigen of hepatitis B virus |
01/09/2001 | US6172192 Polypeptide or peptide associated microorganism infection; for diagnosis and prevention protozoan infection of mammals |
01/09/2001 | US6172188 Fluorescent proteins |
01/09/2001 | US6172187 Mammalian polypeptide associated with immune response; for the modulation of apoptosis |
01/09/2001 | US6172186 Pseudorabies virus protein |
01/09/2001 | US6172116 Use of aminoadamantane compounds as immunoregulators |
01/09/2001 | US6172047 Therapy for nervous system tumors |
01/09/2001 | US6172043 Treatments for neurotoxicity in Alzheimer's disease caused by β amyloid peptides |
01/09/2001 | US6171870 Apparatus for the detection of substances in the blood |
01/09/2001 | US6171868 Generating multiple samples from a dried blood spot; making multiple cutting of a single filter and analyzing each filter |
01/09/2001 | US6171858 Proscess for determining the phototoxicity and/or photosensitivity of substances or mixtures thereof, and uses thereof |
01/09/2001 | US6171849 Apparatus for separating high density lipoprotein from a lipoprotein containing body fluid; for the separation of lipoproteins in sample |
01/09/2001 | US6171838 ratB |
01/09/2001 | US6171830 Efficient purification of mycolic acids, salts or derivatives by dissolving mixture in bi-phasic solvent, subjecting to countercurrent distribution separation with sufficient cycles, then recovering |
01/09/2001 | US6171820 Saturation mutagenesis in directed evolution |
01/09/2001 | US6171815 Human sulfonylurea receptor |
01/09/2001 | US6171811 Method and kit for detecting Helicobacter pylori |
01/09/2001 | US6171807 Mixing together endotoxin neutralizing protein, urea, and fluorescein n-hydroxysuccinimide ester in an aqueous citrate buffer solution, and isolating the labeled protein; for use in testing |
01/09/2001 | US6171806 Isolated peptide defined by SEQ ID NO: 17 and uses thereof |
01/09/2001 | US6171805 Immunoassay diagnosis of periodontal disease by contacting serum sample with cell surface polypeptide of defined amino acid sequence and detecting antibodies which bind to polypeptide |
01/09/2001 | US6171804 Method of determining interdomain orientation and changes of interdomain orientation on ligation |
01/09/2001 | US6171802 Detection and amplification of ligands |
01/09/2001 | US6171801 Methods for releasing a ligand from a complex |
01/09/2001 | US6171799 Immunoassay detection of a v beta 5.3 t cell by contacting tissue sample with a monoclonal antibody which reacts to variable region of beta chain of the receptor; diagnosis and treatment of rheumatoid arthritis |
01/09/2001 | US6171798 Diagnosing cancer or determining p53 status in a sample by comparing level of expression of specific genes to control; lower level indicates cancer |
01/09/2001 | US6171797 Methods of making polymeric arrays |
01/09/2001 | US6171796 Biomarkers and targets for diagnosis prognosis and management of prostate disease |
01/09/2001 | US6171792 Detection systems for registering protein interactions and functional relationships |
01/09/2001 | US6171788 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders |
01/09/2001 | US6171787 Detecting polynucleotide of tumor necrosis factor-gamma in sample by contacting with polynucleotide of defined nucleotide sequence and determining binding/hybridization; diagnosis of inflammation and related disorders |
01/09/2001 | US6171786 Contacting cell with phosphoinositol-dependent phospholipase c inhibitor along with cytotoxic drug |
01/09/2001 | US6171785 Methods and devices for hemogeneous nucleic acid amplification and detector |
01/09/2001 | US6171783 Detecting parainfluenza virus-3 and respiratory syncytial virus infection by using fusion protein of antigenic proteins from both viruses |
01/09/2001 | US6171781 NF-AT polypeptides and polynucleotides |
01/09/2001 | US6171779 HMGI proteins in cancer |
01/09/2001 | US6171598 GTP cyclohydrolase II (RIBA) |
01/09/2001 | US6171592 Equine rhinovirus 1 proteins |
01/09/2001 | US6171589 Are useful in protecting individuals against infections by species of the genus mycoplama. |
01/09/2001 | US6171578 Glycoprotein iib/iiia receptor-binding benzodiazepine derivatives covalently linked to metal ion chelators. |
01/09/2001 | US6171552 Hydride formation analytical apparatus |
01/09/2001 | US6171520 Reagents for labeling SH groups, process for the preparation of them and method for labeling with them |
01/09/2001 | US6171238 Portable hand-held device with a biosensor |
01/09/2001 | US6170671 Blood filter unit |
01/09/2001 | US6170335 Method and apparatus for measuring the characteristics of meat |
01/09/2001 | US6170318 Methods of use for sensor based fluid detection devices |
01/09/2001 | CA2002099C Electrochemiluminescent reaction utilizing amine-derived reductant |
01/09/2001 | CA2002083C Enhanced electrochemiluminescence |
01/04/2001 | WO2001001152A1 Method and apparatus for presenting thrombosis and hemostasis assay data |
01/04/2001 | WO2001001151A2 Evaluation of adenocarcinoma of the prostate and breast using anti-dystroglycan antibodies |
01/04/2001 | WO2001001150A2 Diagnostic test for thrombotic or thromboembolic disease |
01/04/2001 | WO2001001149A1 Troponin i composition |
01/04/2001 | WO2001001148A1 Method for determining the fertility of mammals, especially humans |
01/04/2001 | WO2001001147A1 Assay for degp protease inhibitors |
01/04/2001 | WO2001001146A1 Method of predicting an ability to develop new blood vessels in response to hypoxia or ischemia |
01/04/2001 | WO2001001145A1 Immunoassay supports and immunoasssay solid phases with the use thereof |